Filter News



Showing 1 to 5 of 22 results
As we transition out of the COVID-19 world, you may have recently heard the term “return to normal” from friends, family, or other sources. The return to normal can generate different feelings for different people. For some, it may create happiness, anticipation, and excitedness. However, for our blood cancer community, it can generate feelings of apprehension, anxiety, nervousness, or uncertainty. There are a few strategies and tools that you can use to help yourself as we return to “normal”.
A new partnership between LLSC and BioCanRx will help Canadian scientists expand their ability to conduct clinical trials of CAR T therapy, an important new treatment for some blood cancers that have not responded to other treatments.
Education, Research
Like many people, the onset of COVID-19 in March 2020 was a catalyst for change in my life. Just into my fifties, I decided to quit my job, making a brief return to the classroom, and adding another feather to my professional cap.
If you have CLL, your immune system may be weakened by the disease and from the effects of treatments. This puts you at increased risk when it comes to COVID-19.

Can't find what you are looking for?

Contact our National Office.